Webinar on the latest developments in the analysis of single-cell data, including from transcriptomic and imaging technologies.
First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022
Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to further advance its biomarker discovery platform.